Log In
BCIQ
Print this Print this
 

Predictor C

  Manage Alerts
Collapse Summary General Information
Company Pacific Edge Ltd.
DescriptionPrognostic test using a 32 gene signature for colorectal cancer to discriminate between patients with high risk vs low risk of disease progression
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationCancer, Diagnostic
Indication DetailsPredict risk of disease progression in colorectal cancer patients
Regulatory Designation
PartnerSignature Diagnostics AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today